206 related articles for article (PubMed ID: 2548865)
21. Interpretive criteria for temocillin disk diffusion susceptibility testing.
Fuchs PC; Barry AL; Thornsberry C; Jones RN
Eur J Clin Microbiol; 1985 Feb; 4(1):30-3. PubMed ID: 3872793
[TBL] [Abstract][Full Text] [Related]
22. Susceptibility of Haemophilus influenzae to piperacillin-tazobactam combinations: interpretive criteria and quality control limits for standardized tests.
Barry AL; Fuchs PC; Jorgensen JH; Tenover FC; Allen SD; Hardy DJ; McLaughlin JC
J Clin Microbiol; 1993 Mar; 31(3):751-3. PubMed ID: 8384632
[TBL] [Abstract][Full Text] [Related]
23. Determination of Disk Diffusion and MIC Quality Control Ranges for Nafithromycin (WCK 4873), a New Lactone-Ketolide.
Hackel MA; Karlowsky JA; Dressel D; Sahm DF
J Clin Microbiol; 2017 Oct; 55(10):3021-3027. PubMed ID: 28747372
[TBL] [Abstract][Full Text] [Related]
24. Single-strain regression analysis for determination of interpretive breakpoints for cefoperazone disk diffusion susceptibility testing.
Kronvall G
J Clin Microbiol; 1983 Jun; 17(6):975-80. PubMed ID: 6223938
[TBL] [Abstract][Full Text] [Related]
25. Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacin.
Fuchs PC; Barry AL; Baker C; Murray PR; Washington JA
J Clin Microbiol; 1991 Oct; 29(10):2111-4. PubMed ID: 1939563
[TBL] [Abstract][Full Text] [Related]
26. Analysis of a single reference strain for determination of gentamicin regression line constants and inhibition zone diameter breakpoints in quality control of disk diffusion antibiotic susceptibility testing.
Kronvall G
J Clin Microbiol; 1982 Nov; 16(5):784-93. PubMed ID: 6818249
[TBL] [Abstract][Full Text] [Related]
27. Development of a meropenem susceptibility disc: drug content, preliminary interpretive and quality control criteria and potency bioassay.
Pitkin DH; Sheikh W; Nadler H
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():251-8. PubMed ID: 2808211
[TBL] [Abstract][Full Text] [Related]
28. Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test medium.
Pfaller MA; Jones RN; Washington JA; Koontz FP; Gerlach EH; Erwin ME
Diagn Microbiol Infect Dis; 1992 Feb; 15(2):145-50. PubMed ID: 1315231
[TBL] [Abstract][Full Text] [Related]
29. Interpretive criteria for CI-960, fleroxacin and temafloxacin susceptibility tests with Haemophilus influenzae.
Barrett MS; Jones RN
Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):462-5. PubMed ID: 1330563
[TBL] [Abstract][Full Text] [Related]
30. Susceptibility testing of carumonam: interpretive criteria for 30-microgram disk tests and quality control guidelines for disk diffusion and broth microdilution methods.
Jones RN; Barry AL
J Clin Microbiol; 1987 Nov; 25(11):2243-6. PubMed ID: 3693552
[TBL] [Abstract][Full Text] [Related]
31. Interpretive standards and quality control limits for susceptibility tests with ampicillin-sulbactam combination disks.
Barry AL; Jones RN; Thornsberry C
J Clin Microbiol; 1984 Feb; 19(2):134-9. PubMed ID: 6321543
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of dirithromycin (LY 237216) compared with activities of other macrolide antibiotics.
Yu KW; Neu HC
Antimicrob Agents Chemother; 1990 Sep; 34(9):1839-42. PubMed ID: 2126695
[TBL] [Abstract][Full Text] [Related]
33. Variability of clarithromycin and erythromycin susceptibility tests with Haemophilus influenzae in four different broth media and correlation with the standard disk diffusion test.
Barry AL; Fernandes PB; Jorgensen JH; Thornsberry C; Hardy DJ; Jones RN
J Clin Microbiol; 1988 Nov; 26(11):2415-20. PubMed ID: 2976773
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
Matsuo K; Uete T
Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676
[TBL] [Abstract][Full Text] [Related]
35. Tentative criteria for determining the in vitro susceptibilities of Haemophilus influenzae, including quality control parameters, to two fluoroquinolones (grepafloxacin and PD 131628).
Sewell DL; Barry AL; Allen SD; Fuchs PC; Jorgensen JH; Tenover F
Diagn Microbiol Infect Dis; 1995 Mar; 21(3):175-9. PubMed ID: 7648838
[TBL] [Abstract][Full Text] [Related]
36. Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-microgram) diffusion methods. The Quality Control Study Group.
Jones RN; Kugler KC; Erwin ME; Biedenbach DJ; Beach ML; Pfaller MA
Diagn Microbiol Infect Dis; 1999 Apr; 33(4):247-53. PubMed ID: 10212751
[TBL] [Abstract][Full Text] [Related]
37. Interpretive standards and quality control guidelines for imipenem susceptibility tests with 10-micrograms disks.
Barry AL; Thornsberry C; Gavan TL; Jones RN
J Clin Microbiol; 1984 Nov; 20(5):988-9. PubMed ID: 6439736
[TBL] [Abstract][Full Text] [Related]
38. [Clinical laboratory approach to estimating the effective administration dose of imipenem/cilastatin. Evaluation of the disk susceptibility test and its interpretation system].
Matsuo K; Uete T
Jpn J Antibiot; 1989 Nov; 42(11):2377-92. PubMed ID: 2621780
[TBL] [Abstract][Full Text] [Related]
39. Variability in susceptibilities of Haemophilus influenzae to clarithromycin and azithromycin due to medium pH.
Nilius AM; Beyer JM; Flamm RK; Tanaka SK
J Clin Microbiol; 1997 Jun; 35(6):1311-5. PubMed ID: 9163435
[TBL] [Abstract][Full Text] [Related]
40. Interpretive standards and quality control guidelines for cefpiramide disk susceptibility tests.
Barry AL; Gavan TL; Thornsberry C; Jones RN
J Clin Microbiol; 1985 Oct; 22(4):688-90. PubMed ID: 4077974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
